Heart Disease Trial, Recruiting NCT06738381 Sponsor: Vestre Viken Hospital Trust Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06738381
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who are willing and able to give informed consent and take part as required by the study guidelines
  • People who are currently in hospital due to a planned or unplanned heart or blood vessel disease event, or who have a known diagnosis of hardening or narrowing of the arteries
  • People who have access to a smartphone or tablet

Who may not be able to join:

  • People who have any condition or situation that the study doctor believes could put them at significant risk, affect the study results, or make it difficult for them to take part — this includes (but is not limited to): cognitive impairment, seizure disorders, active thoughts or plans of suicide, substance or alcohol dependence, psychotic illness, major depression, bipolar disorder, currently receiving psychological treatment, or regularly working night shifts
  • People with a short life expectancy (less than 12 months) due to severe organ disease (such as advanced lung disease or advanced kidney disease) or cancer
  • People who currently have significant symptoms of anxiety or depression, as measured by a specific screening tool called the HADS questionnaire (confirm with trial site)
  • People who are not able to understand Norwegian

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4797524194

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Vestre Viken Hospital Trust
Registry
ClinicalTrials.gov
Start date
3 February 2025
Est. completion
20 December 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Attended follow-up visits in primary healthcare; Attended follow-up visits in specialist healthcare

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov